Breaking News Bar

Business News and Information

Bayer to buy AskBIo in deal worth up to $4 billion

A global pharmaceutical company is buying a Triangle-based gene-therapy outfit in a deal that could reach as high as $4 billion.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear